Literature DB >> 25018786

Control of cellular motility by neuropilin-mediated physical interactions.

Xiaobo Li, Matthew W Parker, Craig W Vander Kooi.   

Abstract

The neuropilin (Nrp) family consists of multifunctional cell surface receptors with critical roles in a number of different cell and tissue types. A core aspect of Nrp function is in ligand-dependent cellular migration, where it controls the multistep process of cellular motility through integration of ligand binding and receptor signaling. At a molecular level, the role of Nrp in migration is intimately connected to the control of adhesive interactions and cytoskeletal reorganization. Here, we review the physiological role of Nrp in cellular adhesion and motility in the cardiovascular and nervous systems. We also discuss the emerging pathological role of Nrp in tumor cell migration and metastasis, providing motivation for continued efforts toward developing Nrp inhibitors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25018786      PMCID: PMC4086447          DOI: 10.1515/bmc-2013-0035

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  132 in total

Review 1.  Semaphorin signals in cell adhesion and cell migration: functional role and molecular mechanisms.

Authors:  Andrea Casazza; Pietro Fazzari; Luca Tamagnone
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 2.  The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis.

Authors:  Gera Neufeld; Tzafra Cohen; Niva Shraga; Tali Lange; Ofra Kessler; Yael Herzog
Journal:  Trends Cardiovasc Med       Date:  2002-01       Impact factor: 6.677

3.  A dominant negative receptor for specific secreted semaphorins is generated by deleting an extracellular domain from neuropilin-1.

Authors:  M J Renzi; L Feiner; A M Koppel; J A Raper
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

4.  The PDZ domain of TIP-2/GIPC interacts with the C-terminus of the integrin alpha5 and alpha6 subunits.

Authors:  Haquima El Mourabit; Patrice Poinat; Jan Koster; Holger Sondermann; Viktor Wixler; Elmar Wegener; Emmanuel Laplantine; Dirk Geerts; Elisabeth Georges-Labouesse; Arnoud Sonnenberg; Monique Aumailley
Journal:  Matrix Biol       Date:  2002-03       Impact factor: 11.583

5.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

6.  Differential expression of VEGF isoforms in mouse during development and in the adult.

Authors:  Y S Ng; R Rohan; M E Sunday; D E Demello; P A D'Amore
Journal:  Dev Dyn       Date:  2001-02       Impact factor: 3.780

7.  Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Authors:  Claudia Prahst; Mélanie Héroult; Anthony A Lanahan; Noa Uziel; Ofra Kessler; Niva Shraga-Heled; Michael Simons; Gera Neufeld; Hellmut G Augustin
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

8.  Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse.

Authors:  F Nakamura; M Tanaka; T Takahashi; R G Kalb; S M Strittmatter
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

9.  A requirement for neuropilin-1 in embryonic vessel formation.

Authors:  T Kawasaki; T Kitsukawa; Y Bekku; Y Matsuda; M Sanbo; T Yagi; H Fujisawa
Journal:  Development       Date:  1999-11       Impact factor: 6.868

10.  Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.

Authors:  Andrea Casazza; Boaz Kigel; Federica Maione; Lorena Capparuccia; Ofra Kessler; Enrico Giraudo; Massimiliano Mazzone; Gera Neufeld; Luca Tamagnone
Journal:  EMBO Mol Med       Date:  2012-01-13       Impact factor: 12.137

View more
  1 in total

Review 1.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.